| Matilda Macarthur, | |
|
1313 Honeysuckle St, Cayce, SC 29033-4355 | |
| (989) 284-6568 | |
| Not Available |
| Full Name | Matilda Macarthur |
|---|---|
| Gender | Female |
| Speciality | Occupational Therapist |
| Location | 1313 Honeysuckle St, Cayce, South Carolina |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1609307784 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225X00000X | Occupational Therapist | 4349 (South Carolina) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Matilda Macarthur, 1313 Honeysuckle St, Cayce, SC 29033-4355 Ph: (989) 284-6568 | Matilda Macarthur, 1313 Honeysuckle St, Cayce, SC 29033-4355 Ph: (989) 284-6568 |
News Archive
A new 'closed-loop' system can precisely adjust levels of anesthetics and analgesic drugs in patients undergoing surgery, reports a study in the March issue of Anesthesia & Analgesia, official journal of the International Anesthesia Research Society.
The therapeutic monoclonal antibody CT-P59 binds to the RBD of SARS-CoV-2, the site of these three major mutations, which may therefore reduce the potency of this antibody against the P.1 lineage. In a new study, the neutralizing potency of this monoclonal antibody towards both wildtype and P.1 SARS-CoV-2 is investigated. The researchers found that the ability to bind with the virus is impeded by the mutations, resulting in reduced potency in vitro.
To understand cardiovascular failures, the leading cause of birth defect-related deaths in infants, UH professor of biomedical engineering Kirill Larin is teaming up with Baylor College of Medicine professor of cellular and molecular physiology Irina Larina on a chicken and egg hunt.
A new blood test in development has shown ability to screen for numerous types of cancer with a high degree of accuracy, a trial of the test shows.
XOMA Ltd., a leader in the discovery and development of therapeutic antibodies, announced that the Committee for Orphan Medical Products of the European Medicines Agency (EMA) has adopted a positive opinion and recommends the granting of orphan medicinal product designation for XOMA 052, an antibody to interleukin-1 beta, for the treatment of Behcet's disease. Positive opinions are submitted to the European Commission for decision and are generally adopted within 30 days of receipt.
› Verified 3 days ago
Julianne Price Jones, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 989 Knox Abbott Dr, Suite 400, Cayce, SC 29033 Phone: 803-796-7421 Fax: 803-796-7422 | |
Jordan M Piper, OTR/L Occupational Therapist Medicare: Accepting Medicare Assignments Practice Location: 3799 12th Street Ext Ste 100, Cayce, SC 29033 Phone: 803-926-6810 Fax: 803-926-6811 | |
Mrs. Lou Ann Hudspith, OT Occupational Therapist Medicare: Accepting Medicare Assignments Practice Location: 3799 12th Street Ext Ste 100, Cayce, SC 29033 Phone: 803-926-6810 Fax: 803-926-6811 | |
Allison Dubois Van Dalen, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 989 Knox Abbott Dr, Suite 400, Cayce, SC 29033 Phone: 803-796-7421 Fax: 803-796-7422 |